The global Lyophilized Drugs Market is estimated to be valued at US$ 20 Billion in 2023 and is expected to exhibit a CAGR of 5.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Tag: Antineoplastic
Castrate Resistant Prostate Cancer Market Is Expected To Be Flourished By Focus On Development Of Novel Drugs And Therapies
The global castrate resistant prostate cancer market is estimated to be valued at US$ 11.12 Bn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.